Literature DB >> 24874558

Lost in the jungle: new hurdles for optic nerve axon regeneration.

Vincent Pernet1, Martin E Schwab2.   

Abstract

The poor regenerative capacity of injured central nervous system (CNS) axons leads to permanent neurological deficits after brain, spinal cord, or optic nerve lesions. In the optic nerve, recent studies showed that stimulation of the cytokine or mammalian target of rapamycin (mTOR) signaling pathways potently enhances sprouting and regeneration of injured retinal ganglion cell axons in adult mice, but does not allow the majority of axons to reach their main cerebral targets. New analyses have revealed axon navigation defects in the optic nerve and at the optic chiasm under conditions of strong growth stimulation. We propose that a balanced growth stimulatory treatment will have to be combined with guidance factors and suppression of local growth inhibitory factors to obtain the full regeneration of long CNS axonal tracts.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Stat3; axonal misguidance; axonal regeneration; mTOR; neurotrophic factors; optic nerve injury

Mesh:

Substances:

Year:  2014        PMID: 24874558     DOI: 10.1016/j.tins.2014.05.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  38 in total

1.  A Self-Assembling Injectable Biomimetic Microenvironment Encourages Retinal Ganglion Cell Axon Extension in Vitro.

Authors:  Melissa R Laughter; David A Ammar; James R Bardill; Brisa Pena; Malik Y Kahook; David J Lee; Daewon Park
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-02       Impact factor: 9.229

Review 2.  Optic nerve regeneration in mammals: Regenerated or spared axons?

Authors:  Dietmar Fischer; Alan R Harvey; Vincent Pernet; Vance P Lemmon; Kevin K Park
Journal:  Exp Neurol       Date:  2017-07-14       Impact factor: 5.330

3.  Overexpression of Sox11 promotes corticospinal tract regeneration after spinal injury while interfering with functional recovery.

Authors:  Zimei Wang; Ashley Reynolds; Adam Kirry; Christopher Nienhaus; Murray G Blackmore
Journal:  J Neurosci       Date:  2015-02-18       Impact factor: 6.167

4.  Identification of Retinal Ganglion Cells from β-III Stained Fluorescent Microscopic Images.

Authors:  He Gai; Yi Wang; Leanne L H Chan; Bernard Chiu
Journal:  J Digit Imaging       Date:  2020-10       Impact factor: 4.056

Review 5.  Special Commentary: Early Clinical Development of Cell Replacement Therapy: Considerations for the National Eye Institute Audacious Goals Initiative.

Authors:  Leonard A Levin; Joan W Miller; Donald J Zack; Martin Friedlander; Lois E H Smith
Journal:  Ophthalmology       Date:  2017-03-29       Impact factor: 12.079

6.  Wnt signaling promotes axonal regeneration following optic nerve injury in the mouse.

Authors:  Amit K Patel; Kevin K Park; Abigail S Hackam
Journal:  Neuroscience       Date:  2016-12-21       Impact factor: 3.590

7.  Raf-1 Kinase Inhibitory Protein (RKIP) Promotes Retinal Ganglion Cell Survival and Axonal Regeneration Following Optic Nerve Crush.

Authors:  Jie Wei; Hua Jiang; Hongrui Gao; Guangjie Wang
Journal:  J Mol Neurosci       Date:  2015-07-10       Impact factor: 3.444

8.  Applying proteomics to research for optic nerve regeneration in glaucoma: what's on the horizon?

Authors:  Gülgün Tezel
Journal:  Expert Rev Proteomics       Date:  2016-09-24       Impact factor: 3.940

9.  The effect of extrinsic Wnt/β-catenin signaling in Muller glia on retinal ganglion cell neurite growth.

Authors:  Ganeswara Rao Musada; Galina Dvoriantchikova; Ciara Myer; Dmitry Ivanov; Sanjoy K Bhattacharya; Abigail S Hackam
Journal:  Dev Neurobiol       Date:  2020-04-17       Impact factor: 3.964

10.  Optogenetic Interrogation of Functional Synapse Formation by Corticospinal Tract Axons in the Injured Spinal Cord.

Authors:  Naveen Jayaprakash; Zimei Wang; Brian Hoeynck; Nicholas Krueger; Audra Kramer; Eric Balle; Daniel S Wheeler; Robert A Wheeler; Murray G Blackmore
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.